Document is current

Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

Crossref DOI link: https://doi.org/10.1007/s11883-016-0614-1

Published Online: 2016-09-09

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy